Munafa Stock Market Course + Intraday & FNO calls 
Sonoma Pharmaceuticals (SNOA) Technical (Analysis) Reports Sonoma Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Sonoma Pharmaceuticals (SNOA)
Technical Analysis Report for NASDAQ stock SNOA Sonoma Pharmaceuticals. Dated: 05 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock SNOA Sonoma Pharmaceuticals then click here. or read Experts views on Sonoma Pharmaceuticals or Forecast & share price targets of Sonoma Pharmaceuticals
Sonoma Pharmaceuticals Opened at 3.46 and Closed at: 3.49, which is -2.29% of previous session's close. It moved within a range of 3.46 and 3.90
The session was a Bullish session with an average volume of 42300, which is 24.59% of previous session's volumes.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
A Dead cross was found 1 days back on long term averages
Support for tomorrow is 3.48 and resistance for tomorrow is 3.92
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 3.33, 3.18 resistance for tomorrow's hourly charts is 3.77, 4.06
10 Day SMA for Sonoma Pharmaceuticals (SNOA) is 3.29 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Sonoma Pharmaceuticals (SNOA) is 3.42 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Sonoma Pharmaceuticals (SNOA) is 3.74 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 3.92 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Sonoma Pharmaceuticals is 3.44 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Sonoma Pharmaceuticals is at 3.42 and 200 DMA is at 3.44, while 50 DMA and 100 DMA are at 3.74 and 3.92 respectively
Sonoma Pharmaceuticals (SNOA) moving average of 20 SMA is at 3.42 and 20 EMA is at 3.44
| Date | Closing Price | 20 SMA | 20 EMA |
| 05 Fri Dec | 3.49 | 3.42 | 3.44 |
| 04 Thu Dec | 3.57 | 3.43 | 3.43 |
| 03 Wed Dec | 3.16 | 3.43 | 3.41 |
| 02 Tue Dec | 3.17 | 3.46 | 3.44 |
| 01 Mon Dec | 3.22 | 3.5 | 3.47 |
| 28 Fri Nov | 3.33 | 3.54 | 3.5 |
Sonoma Pharmaceuticals (SNOA) moving average of 50 SMA is at 3.74 and 50 EMA is at 3.67
| Date | Closing Price | 50 SMA | 50 EMA |
| 05 Fri Dec | 3.49 | 3.74 | 3.67 |
| 04 Thu Dec | 3.57 | 3.75 | 3.68 |
| 03 Wed Dec | 3.16 | 3.76 | 3.68 |
| 02 Tue Dec | 3.17 | 3.78 | 3.7 |
| 01 Mon Dec | 3.22 | 3.8 | 3.72 |
| 28 Fri Nov | 3.33 | 3.82 | 3.74 |
Sonoma Pharmaceuticals (SNOA) moving average of 100 SMA is at 3.92 and 100 EMA is at 3.7
| Date | Closing Price | 100 SMA | 100 EMA |
| 05 Fri Dec | 3.49 | 3.92 | 3.7 |
| 04 Thu Dec | 3.57 | 3.92 | 3.7 |
| 03 Wed Dec | 3.16 | 3.92 | 3.7 |
| 02 Tue Dec | 3.17 | 3.92 | 3.71 |
| 01 Mon Dec | 3.22 | 3.93 | 3.72 |
| 28 Fri Nov | 3.33 | 3.94 | 3.73 |
Sonoma Pharmaceuticals (SNOA) moving average of 200 SMA is at 3.44 and 200 EMA is at 3.41
| Date | Closing Price | 200 SMA | 200 EMA |
| 05 Fri Dec | 3.49 | 3.44 | 3.41 |
| 04 Thu Dec | 3.57 | 3.43 | 3.41 |
| 03 Wed Dec | 3.16 | 3.43 | 3.41 |
| 02 Tue Dec | 3.17 | 3.42 | 3.41 |
| 01 Mon Dec | 3.22 | 3.42 | 3.41 |
| 28 Fri Nov | 3.33 | 3.42 | 3.41 |
Vistagen Therapeutics has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Vistagen Therapeutics, about 13.68% more returns!
Urogen Pharma has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Urogen Pharma, about 4.04% more returns!
Scholar Rock has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Scholar Rock, about 60.67% more returns!
Redhill Biopharma has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Redhill Biopharma, about 10.42% more returns!
Ptc Therapeutics has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Ptc Therapeutics, about 12.78% more returns!
Sonoma Pharmaceuticals has performed better than Prophase Labs in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!
Opko Health has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Opko Health, about 4.42% more returns!
Arbutus Biopharma has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Arbutus Biopharma, about 3.38% more returns!
Achieve Life has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Achieve Life, about 5.81% more returns!
Sonoma Pharmaceuticals has performed better than Alkermes Plc in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!
Sonoma Pharmaceuticals has performed better than Array Biopharma in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!
Arrowhead Pharmaceuticals has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Arrowhead Pharmaceuticals, about 61.73% more returns!
Aytu Bioscience has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Aytu Bioscience, about 14.52% more returns!
Sonoma Pharmaceuticals has performed better than Electrocore Inc in short term. Holding Sonoma Pharmaceuticals could be a better choice for now!
Gossamer Bio has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Gossamer Bio, about 46.26% more returns!
Icon Plc has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Icon Plc, about 21.96% more returns!
Incyte Corporation has performed better than Sonoma Pharmaceuticals in short term. You could have earned much better returns by investing in Incyte Corporation, about 1.9% more returns!
Sonoma Pharmaceuticals Technical analysis of indicators
Price action analysis of Sonoma Pharmaceuticals (SNOA) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
ADX buy sell signal for Sonoma Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Sonoma Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Sonoma Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a buy signal for Sonoma Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Sonoma Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.32 and Sonoma Pharmaceuticals SNOA stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Sonoma Pharmaceuticals SNOA stock. Volume based technical analysis of Sonoma Pharmaceuticals SNOA stock is negative.
Sonoma Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock SNOA Sonoma Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And SNOA Experts View which covers a lot of information including buying and selling signals
SNOA future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Sonoma Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Sonoma Pharmaceuticals (SNOA) Technical (Analysis) Reports Sonoma Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
